Erlotinib is an inhibitor of human epidermal growth factor approved for treating non-small cell lung cancer
This sustained benefit aligned with Bifidobacterium enrichment in prebiotic recipients, vs
Vethody C, Yu R, Keck JM, Onasch MK, Stone CA et al (2021) Safety, efficacy, and effectiveness of delabeling in patients with multiple drug allergy labels
BPC-157 (Body Protection Compound-157) Investigational synthetic gastric-derived peptide (regenerative / cytoprotective) Pre-filled pen BPC-157 is a synthetic peptide based on a sequence identified in gastric juice
Products are prepared, packaged, and distributed within the United States, ensuring dependable fulfillment and professional handling